March 24, 2020 / 12:38 PM / 5 days ago

BRIEF-Promore Pharma Reached The Targeted Number Of Patients Completing Treatment

March 24 (Reuters) - Promore Pharma AB:

* PROMORE PHARMA REACHED THE TARGETED NUMBER OF PATIENTS COMPLETING TREATMENT IN THE HEAL LL-37 PHASE IIB CLINICAL TRIAL

* PROMORE PHARMA AB - ASSESSES THAT RESULTS FROM STUDY CAN BE PRESENTED IN Q4 2020 IN ACCORDANCE WITH EARLIER COMMUNICATIONS.

* PROMORE PHARMA AB - REACHED ITS TARGET OF TREATING 120 PATIENTS WITH LL-37 FOR THREE MONTHS. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below